Mobile phones do not cause eye cancer

Article

The use of mobile telephones does not increase the risk of uveal melanoma, according to a study published online ahead of print by the Journal of the National Cancer Institute.

The use of mobile telephones does not increase the risk of uveal melanoma, according to a study published online ahead of print by the Journal of the National Cancer Institute.

Andreas Stang, MD, MPH of the Martin Luther University of Halle-Wittenberg, Halle, Germany and colleagues conducted a case-control study of uveal melanoma patients (n=459) and control subjects (n=1194) drawn from the general population, melanoma patients’ siblings and ophthalmologists’ offices. The team used a questionnaire to assess any correlation between melanoma and self-assessed mobile phone use (regular, sporadic and never).

The researchers found that, even among regular mobile telephone users, the incidence of uveal melanoma development was similar to that among the control group: odds ratio (OR) = 0.7, 95% confidence interval (CI) = 0.5 to 1.0 versus population control subjects; OR = 1.1, 95% CI = 0.6 to 2.3 versus ophthalmologist control subjects; and OR = 1.2, 95% CI =0.5 to 2.6 versus sibling control subjects.

Thus the researchers concluded that, up to ten years, mobile telephone use is not correlated with an increased risk of uveal melanoma. This conclusion is in contrast to earlier study results showing a relationship between mobile phone exposure and melanoma development.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.